Cantor Fitzgerald Starts Given Imaging (GIVN) at Buy; Keep Your Eyes on the Prize

Cantor Fitzgerald initiates coverage on Given Imaging (NASDAQ: GIVN) with a Buy. PT $23.00.

Cantor analyst said, "Given's consistently solid operating results in the face of weak patient volumes in the U.S. and continuing economic uncertainty in Europe are a testament to its strong product innovation and management, in our opinion. While there is plenty to like about the base business and balance sheet, we believe that Colon 2 remains the reason to own this stock. Even with the recent strength in shares, we would still be buyers here."

For an analyst ratings summary and ratings history on Given Imaging click here. For more ratings news on Given Imaging click here.

Shares of Given Imaging closed at $17.27 yesterday, with a 52 week range of $13.53-$22.92.

---

Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!

You May Also Be Interested In

• UPDATE: William Blair Starts EPIQ Systems (EPIQ) at Outperform; Broad Suite of Solutions in Electronic Discovery Sector
• Barclays Cuts Estimates and Price Target on ADP (ADP); Mixed Data From Investor Day
• Citi, Oppenheimer, William Blair Starts Acquity (AQ) at Buy/Outperform

Create E-mail Alert Related Categories

New Coverage

Related Entities

Cantor Fitzgerald

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?

Follow StreetInsider.com On Twitter